Financial Reports and Analysis related to anselamimab

•

Form 6-K

•

2025-07-16

Last updated: about 1 month ago

Explore AstraZeneca's latest report on anselamimab's Phase III trial for AL amyloidosis, highlighting key findings and future steps.

Posts With Tag anselamimab